| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Breast magnetic resonance imaging as a problem solving tool in women recalled at biennial screening mammography: A population-based study in the Netherlands
|
Gommers, Jessie JJ.
|
|
|
60 |
C |
p. 279-286
|
artikel
|
| 2 |
Can population breast screening programs be leveraged to reduce the burden of breast cancer?
|
Houssami, Nehmat
|
|
|
60 |
C |
p. 245-246
|
artikel
|
| 3 |
Chronic pain assessment and management during post-treatment follow up should be considered as a high value quality indicator for specialist breast cancer center
|
Motiaa, Y.
|
|
|
60 |
C |
p. 308
|
artikel
|
| 4 |
Contralateral parenchymal enhancement on MRI is associated with tumor proteasome pathway gene expression and overall survival of early ER+/HER2-breast cancer patients
|
Ragusi, Max A.A.
|
|
|
60 |
C |
p. 230-237
|
artikel
|
| 5 |
Correspondence to “Locoregional therapy in de novo metastatic breast cancer: Systematic review and meta-analysis, written by Reinhorn D et al. In The Breast Journal 58 (2021) 173–181”
|
Soran, Atilla
|
|
|
60 |
C |
p. 304-305
|
artikel
|
| 6 |
COVID-19 vaccination in patients with breast cancer and gynecological malignancies: A German perspective
|
Forster, Marie
|
|
|
60 |
C |
p. 214-222
|
artikel
|
| 7 |
Development of a novel nomogram-based online tool to predict axillary status after neoadjuvant chemotherapy in cN+ breast cancer: A multicentre study on 1,950 patients
|
Corsi, Fabio
|
|
|
60 |
C |
p. 131-137
|
artikel
|
| 8 |
Editorial Board
|
|
|
|
60 |
C |
p. i
|
artikel
|
| 9 |
Effects of postmastectomy radiotherapy on survival in different age groups for patients with T3N0M0 breast cancer
|
He, Meng-Ting
|
|
|
60 |
C |
p. 247-254
|
artikel
|
| 10 |
Efficacy and safety of PARP inhibitors in patients with BRCA-mutated advanced breast cancer: A meta-analysis and systematic review
|
Sun, Ximu
|
|
|
60 |
C |
p. 26-34
|
artikel
|
| 11 |
Evidence-based tailored nutrition educational intervention improves adherence to dietary guidelines, anthropometric measures and serum metabolic biomarkers in early-stage breast cancer patients: A prospective interventional study
|
Trestini, Ilaria
|
|
|
60 |
C |
p. 6-14
|
artikel
|
| 12 |
Factors involved in treatment decision making for women diagnosed with ductal carcinoma in situ: A qualitative study
|
Hatton, Amy
|
|
|
60 |
C |
p. 123-130
|
artikel
|
| 13 |
First-line bevacizumab-containing therapy for HER2-negative locally advanced/metastatic breast cancer: Real-world experience from >2000 patients treated in the multicentre AVANTI study
|
Müller, Volkmar
|
|
|
60 |
C |
p. 70-77
|
artikel
|
| 14 |
Fixed dose combination of capecitabine and cyclophosphamide in metastatic breast cancer: Results from THE ENCLOSE phase 2/3 randomized multicenter study
|
Gupta, Sudeep
|
|
|
60 |
C |
p. 147-154
|
artikel
|
| 15 |
Genetic heterogeneity during breast cancer progression in young patients
|
Hagio, Kanako
|
|
|
60 |
C |
p. 206-213
|
artikel
|
| 16 |
Immediate direct-to-implant breast reconstruction with acellular dermal matrix: Evaluation of complications and safety
|
Kalstrup, Julie
|
|
|
60 |
C |
p. 192-198
|
artikel
|
| 17 |
Information needs on breast cancer genetic and non-genetic risk factors in relatives of women with a BRCA1/2 or PALB2 pathogenic variant
|
Brédart, Anne
|
|
|
60 |
C |
p. 38-44
|
artikel
|
| 18 |
Interassay and interobserver comparability study of four programmed death-ligand 1 (PD-L1) immunohistochemistry assays in triple-negative breast cancer
|
Noske, Aurelia
|
|
|
60 |
C |
p. 238-244
|
artikel
|
| 19 |
Machine learning to predict individual patient-reported outcomes at 2-year follow-up for women undergoing cancer-related mastectomy and breast reconstruction (INSPiRED-001)
|
Pfob, André
|
|
|
60 |
C |
p. 111-122
|
artikel
|
| 20 |
Magnetic resonance imaging radiomics signatures for predicting endocrine resistance in hormone receptor-positive non-metastatic breast cancer
|
Yang, Yaping
|
|
|
60 |
C |
p. 90-97
|
artikel
|
| 21 |
Metastasectomy versus radiation of secondary sites in stage IV breast cancer: Analysis from a national cancer registry
|
Bilani, Nadeem
|
|
|
60 |
C |
p. 185-191
|
artikel
|
| 22 |
Multidisciplinary team meeting as a highly recommended EUSOMA criteria evaluating the quality of breast cancer management between centers
|
Souadka, Amine
|
|
|
60 |
C |
p. 310
|
artikel
|
| 23 |
Nomogram for the personalisation of radiotherapy treatments in breast cancer patients
|
Beato Tortajada, Inmaculada
|
|
|
60 |
C |
p. 255-262
|
artikel
|
| 24 |
Novel prognostic classification predicts overall survival of patients receiving salvage whole-brain radiotherapy for recurrent brain metastasis from breast cancer: A recursive partitioning analysis (KROG 16-12)
|
Kim, Jae Sik
|
|
|
60 |
C |
p. 272-278
|
artikel
|
| 25 |
Ovarian reserve of women with and without BRCA pathogenic variants: A systematic review and meta-analysis
|
Gasparri, Maria Luisa
|
|
|
60 |
C |
p. 155-162
|
artikel
|
| 26 |
Palbociclib dose reductions and the effect on clinical outcomes in patients with advanced breast cancer
|
Ismail, R.K.
|
|
|
60 |
C |
p. 263-271
|
artikel
|
| 27 |
Palbociclib in combination with aromatase inhibitors in patients ≥ 75 years with oestrogen receptor-positive, human epidermal growth factor receptor 2 negative advanced breast cancer: A real-world multicentre UK study
|
El Badri, Salma
|
|
|
60 |
C |
p. 199-205
|
artikel
|
| 28 |
Positive effects of the enhanced recovery after surgery (ERAS) protocol in DIEP flap breast reconstruction
|
Gort, N.
|
|
|
60 |
C |
p. 53-57
|
artikel
|
| 29 |
Presentation and survival by hormonal receptor status in metaplastic breast cancer: A propensity score-matched analysis
|
Wang, Siqin
|
|
|
60 |
C |
p. 168-176
|
artikel
|
| 30 |
Prognostic impact of HER2-low expression in hormone receptor positive early breast cancer
|
Mutai, Raz
|
|
|
60 |
C |
p. 62-69
|
artikel
|
| 31 |
Rates of margin positive resection with breast conservation for invasive breast cancer using the NCDB
|
WJ, Hotsinpiller
|
|
|
60 |
C |
p. 86-89
|
artikel
|
| 32 |
RE: Cost-utility of talazoparib monotherapy treatment for locally advanced or metastatic breast cancer in Spain
|
Zou, Denise
|
|
|
60 |
C |
p. 302
|
artikel
|
| 33 |
Reply to: Chronic pain assessment and management during post-treatment follow up should be considered as a high value quality indicator for specialist breast cancer center
|
Mrabti, Hind
|
|
|
60 |
C |
p. 309
|
artikel
|
| 34 |
Research on the cutoff tumor size of omitting radiotherapy for BCSS after breast conserving surgery in women aged 65 years or oder with low-risk invasive breast carcinoma: Results based on the SEER database
|
Yang, Zejian
|
|
|
60 |
C |
p. 287-294
|
artikel
|
| 35 |
Response to Soran et al.
|
Reinhorn, Daniel
|
|
|
60 |
C |
p. 306-307
|
artikel
|
| 36 |
Response to the letter to the editor
|
Olry de Labry Lima, Antonio
|
|
|
60 |
C |
p. 303
|
artikel
|
| 37 |
SABR in oligometastatic breast cancer: Current status and future directions
|
Stewart, Rachel
|
|
|
60 |
C |
p. 223-229
|
artikel
|
| 38 |
Safety of cyclin-dependent kinase4/6 inhibitor combined with palliative radiotherapy in patients with metastatic breast cancer
|
Kim, Kristine N.
|
|
|
60 |
C |
p. 163-167
|
artikel
|
| 39 |
SARS-CoV-2 neutralizing antibodies after first vaccination dose in breast cancer patients receiving CDK4/6 inhibitors
|
Zagouri, Flora
|
|
|
60 |
C |
p. 58-61
|
artikel
|
| 40 |
Tailored axillary surgery in patients with clinically node-positive breast cancer: Pre-planned feasibility substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)
|
Weber, Walter P.
|
|
|
60 |
C |
p. 98-110
|
artikel
|
| 41 |
Targeting ADCC: A different approach to HER2 breast cancer in the immunotherapy era
|
Mandó, Pablo
|
|
|
60 |
C |
p. 15-25
|
artikel
|
| 42 |
The association between endocrine therapy use and osteoporotic fracture among post-menopausal women treated for early-stage breast cancer in Ontario, Canada
|
Blanchette, Phillip S.
|
|
|
60 |
C |
p. 295-301
|
artikel
|
| 43 |
The effect of postmastectomy radiation therapy on high-risk patients with T1-2N0 breast cancer
|
Luo, Chuanxu
|
|
|
60 |
C |
p. 1-5
|
artikel
|
| 44 |
The impact of tumor detection method on genomic and clinical risk and chemotherapy recommendation in early hormone receptor positive breast cancer
|
Bar, Yael
|
|
|
60 |
C |
p. 78-85
|
artikel
|
| 45 |
Treatment and outcomes of older versus younger women with HER2-positive metastatic breast cancer in the real-world national ESME database
|
Annonay, Mylène
|
|
|
60 |
C |
p. 138-146
|
artikel
|
| 46 |
Underutilisation of breast cancer prevention medication in Australia
|
Macdonald, Courtney
|
|
|
60 |
C |
p. 35-37
|
artikel
|
| 47 |
Unique challenges and outcomes of young women with breast cancers from a tertiary care cancer centre in India
|
Bajpai, Jyoti
|
|
|
60 |
C |
p. 177-184
|
artikel
|
| 48 |
Uptake of bilateral-risk-reducing-mastectomy: Prospective analysis of 7195 women at high-risk of breast cancer
|
Evans, D.Gareth
|
|
|
60 |
C |
p. 45-52
|
artikel
|
Tijdschrift beschrijving